{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:38:01Z","timestamp":1787164681707,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T00:00:00Z","timestamp":1557014400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["ZIA NS003034"],"award-info":[{"award-number":["ZIA NS003034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.parkreldis.2018.02.023","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T13:27:19Z","timestamp":1518701239000},"page":"108-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-9940","authenticated-orcid":false,"given":"David S.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grisel J.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehonatan","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parkreldis.2018.02.023_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2018.02.023_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jnc.13997","article-title":"Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia","volume":"141","author":"Andersen","year":"2017","journal-title":"J.\u00a0Neurochem."},{"issue":"3","key":"10.1016\/j.parkreldis.2018.02.023_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.22311","article-title":"Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression","volume":"69","author":"Shi","year":"2011","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2018.02.023_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson's disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.parkreldis.2018.02.023_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2018.02.023_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10286-006-0317-8","article-title":"Orthostatic hypotension as an early finding in Parkinson disease","volume":"16","author":"Goldstein","year":"2006","journal-title":"Clin. Auton. Res."},{"issue":"Pt 6","key":"10.1016\/j.parkreldis.2018.02.023_bib7","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/aws055","article-title":"Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies","volume":"135","author":"Goldstein","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2018.02.023_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.1139","article-title":"Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study","volume":"16","author":"Nurmi","year":"2001","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2018.02.023_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","article-title":"Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls","volume":"50","author":"Jokinen","year":"2009","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.parkreldis.2018.02.023_bib10","article-title":"Wu, Tianxia, Y. Sharabi, Cardiac sympathetic denervation predicts PD in at-risk individuals","author":"Goldstein","year":"2017","journal-title":"Park. Relat. Disord."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018300592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802018300592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:21Z","timestamp":1761178461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802018300592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":10,"alternative-id":["S1353802018300592"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.023","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2018.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}